Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice.
Latasa MU, Gil-Puig C, Fernández-Barrena MG, Rodríguez-Ortigosa CM, Banales JM, Urtasun R, Goñi S, Méndez M, Arcelus S, Juanarena N, Recio JA, Lotersztajn S, Prieto J, Berasain C, Corrales FJ, Lecanda J, Avila MA.
Latasa MU, et al.
PLoS One. 2010 Dec 29;5(12):e15690. doi: 10.1371/journal.pone.0015690.
PLoS One. 2010.
PMID: 21209952
Free PMC article.